Attorneys associated with PPI lawsuits filed a proposal in the Superior Court of the State of Delaware on June 11 seeking coordination between MDL and Delaware Litigation. With this order, the parties hope to avoid any duplicate discovery while proceeding with the federal multidistrict litigation (MDL).
The court order states, ‘’the court and the parties are mindful of the desire for the efficiencies to be gained through the non-duplication of discovery between the Delaware PPI Actions and discovery taking place in the other consolidated actions.’’ Both parties are required to make serious efforts to minimize duplicate motions.
More than 4,500 lawsuits against Nexium, Prilosec, and other heartburn drugs continue to be linked to claims of kidney malfunction. Lawsuits over PPIs are filed across the U.S., which are centralized as a part of multidistrict litigation (MDL No. 2789; In Re: Proton-Pump Inhibitor Products Liability Litigation |LS|No. II|RS|) in the District of New Jersey before Judge Claire C. Cecchi for coordinated discovery and pretrial proceedings.
